Position in PFE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$5,830,586
-$1,046,599 QoQ
Shares Held
242,134
-1.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
3.73%
of 13F equity value
Holder Rank
#549
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Round Hill Asset Management holds $42,939,237 across 7 Drug Manufacturers - General names. PFE ranks #4 (13.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
37,380 | $13,536,045 | |
| 2 | MRK |
Merck & Co., Inc.
|
71,350 | $9,168,475 | |
| 3 | NVO |
Novo Nordisk A S
|
122,031 | $5,850,166 | |
| 4 | PFE |
Pfizer Inc
This page
|
242,134 | $5,830,586 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
71,646 | $4,128,242 | |
| 6 | ABBV |
AbbVie Inc.
|
15,475 | $3,894,129 | |
| 7 | NVS |
Novartis AG
|
3,392 | $531,594 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,830,586 | 242,134 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $6,877,185 | 244,914 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $6,156,873 | 247,264 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $6,319,524 | 248,019 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $6,002,939 | 247,646 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,644,061 | 183,270 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $4,036,857 | 152,162 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,070,353 | 140,648 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,980,798 | 142,273 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $4,032,213 | 145,305 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $4,228,675 | 146,880 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,921,930 | 148,385 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,553,352 | 151,400 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,264,840 | 153,550 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $8,085,928 | 157,805 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,959,152 | 159,030 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,357,604 | 159,405 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $8,259,023 | 159,533 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $9,476,816 | 160,488 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $6,902,588 | 160,488 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $6,341,492 | 161,938 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $5,883,317 | 162,388 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $5,988,250 | 162,680 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $5,979,525 | 162,930 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $5,354,205 | 163,737 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $5,418,297 | 166,002 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||